Financiere Des Professionnels Fonds D,Investissement Inc. Abbott Laboratories Transaction History

Financiere Des Professionnels Fonds D,Investissement Inc.

$1.28 Trillion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $1.58 Million - $1.75 Million	-14,442 Reduced 64.78%	7,852 $892 Million
Q4 2023 Jan 16, 2024	BUY	$90.19 - $110.4 $16,414 - $20,092	182 Added 0.82%	22,294 $2.45 Billion
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $2.11 Million - $2.53 Million	22,112 New	22,112 $2.14 Billion

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

Vanguard Group Inc Valley Forge, PA

166M
Shares

$18.7 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.7 Billion
0.31% of portfolio
State Street Corp Boston, MA

74.4M
Shares

$8.35 Billion
0.34% of portfolio
Capital International Investors Los Angeles, CA

71.8M
Shares

$8.06 Billion
1.57% of portfolio
Capital Research Global Investors Los Angeles, CA

57.2M
Shares

$6.42 Billion
1.34% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financiere Des Professionnels Fonds D,Investissement Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financiere Des Professionnels Fonds D,Investissement Inc. with notifications on news.

Account